Modulator of bone morphogenetic protein activity in the progression of kidney diseases

Kidney International

Volumn 70, Issue 6, 2006, Pages 989-993

  Yanagita, M ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

BMP 7; Ectodin; Gremlin; KCP; Kidney diseases; Wise

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CHORDIN; NOGGIN; SECRETORY PROTEIN; SMAD1 PROTEIN; UNCLASSIFIED DRUG; USAG 1;

HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENAL PROTECTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; DISEASE PROGRESSION; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 33748427629     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001731     Document Type: Short Survey

References (23)

1. Ozkaynak E, Schnegelsberg PN, Oppermann H. Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun 1991; 179: 116-123.
2. Luo G, Hofmann C, Bronckers AL et al. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995; 9: 2808-2820.
3. Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995; 9: 2795-2807.
4. Gould SE, Day M, Jones SS et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 2002; 61: 51-60.
5. Hruska KA. Treatment of chronic tubulointerstitial disease: a new concept. Kidney Int 2002; 61: 1911-1922.
6. Morrissey J, Hruska K, Guo G et al. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13(Suppl 1): S14-S21.
7. Vukicevic S, Basic V, Rogic D et al. Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 1998; 102: 202-214.
8. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968.
9. Vukicevic S, Latin V, Chen P et al. Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes. Biochem Biophys Res Commun 1994; 198: 693-700.
10. Gregory KE, Ono RN, Charbonneau NL et al. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J Biol Chem 2005; 280: 27970-27980.
11. Yanagita M. BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev 2005; 16: 309-317.
12. Michos O, Panman L, Vintersten K et al. Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 2004; 131: 3401-3410.
13. McMahon JA, Takada S, Zimmerman LB et al. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 1998; 12: 1438-1452.
14. Yanagita M, Okuda T, Endo S et al. Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 2006; 116: 70-79.
15. Yanagita M, Oka M, Watabe T et al. USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney. Biochem Biophys Res Commun 2004; 316: 490-500.
16. Laurikkala J, Kassai Y, Pakkasjarvi L et al. Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot. Dev Biol 2003; 264: 91-105.
17. Kassai Y, Munne P, Hotta Y et al. Regulation of mammalian tooth cusp patterning by ectodin. Science 2005; 309: 2067-2070.
18. Kusu N, Laurikkala J, Imanishi M et al. Sclerostin is a novel secreted osteoblast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem 2003; 278: 24113-24117.
19. Winkler DG, Sutherland MK, Geoghegan JC et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J 2003; 22: 6267-6276.
20. van Bezooijen RL, Roelen BA, Visser A et al. Sclerostin is an osteocyteexpressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004; 199: 805-814.
21. Li X, Zhang Y, Kang H et al. Sclerostin binds to LRP 5/6 and antagonizes canonical wnt signaling. J Biol Chem 2005; 280: 19883-19887.
22. Itasaki N, Jones CM, Marcurio N et al. Wise, a context dependent activator and inhibitor of wnt signaling. Development 2003; 130: 4295-4305.
23. Lin J, Patel SR, Cheng X et al. Kielin/chordin-like protein, a novel enhancer of BMP signaling, attenuates renal fibrotic disease. Nat Med 2005; 11: 387-393.